Cellyan Biotechnology Co., Ltd (HKPD) 은(는) 상장 기업입니다 헬스케어 섹터의 Medical - Pharmaceuticals 산업에서 운영. 본사 소재지는 Yau Tong, 홍콩. 현재 CEO는 Chenyu Liang.
HKPD 을(를) 보유 IPO 날짜 2025-01-15, 27 명의 정규직 직원, 에 상장 NASDAQ Capital Marke, 시가총액 $7.63M.
Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers custom clearance, drugs enlisting, warehouse, and other logistics services. The company serves e-commerce platform logistics partners, merchants, and pharmaceutical distributors. The company was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and changed its name to Cellyan Biotechnology Co., Ltd in December 2025. Cellyan Biotechnology Co., Ltd was incorporated in 2023 and is based in Yau Tong, Hong Kong.
